MacroGenics - 48 Year Dividend Yield History | MGNX

Historical dividend payout and yield for MacroGenics (MGNX) since 1971. The current TTM dividend payout for MacroGenics (MGNX) as of March 20, 2019 is $0.00. The current dividend yield for MacroGenics as of March 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.921B $0.060B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.447B 27.76
Medtronic (MDT) Ireland $124.271B 18.17
Stryker (SYK) United States $73.087B 26.83
Baxter (BAX) United States $39.768B 25.44
Zimmer Biomet Holdings (ZBH) United States $25.701B 16.45
Smith & Nephew SNATS (SNN) United Kingdom $17.481B 0.00
ResMed (RMD) United States $14.029B 26.60
Hill-Rom Holdings (HRC) United States $6.960B 21.53
Perrigo (PRGO) Ireland $6.690B 10.85
Phibro Animal Health (PAHC) United States $1.294B 18.60
Meridian Bioscience (VIVO) United States $0.705B 21.00
LeMaitre Vascular (LMAT) United States $0.610B 29.03
Utah Medical Products (UTMD) United States $0.313B 20.35
Owens & Minor (OMI) United States $0.283B 3.91
United-Guardian (UG) United States $0.088B 18.33